NAD+ 1g & Tirzepatide - A UK Update
The recent landscape of metabolic health in the UK is seeing significant interest in the pairing of high-dose Nicotinamide Adenine Dinucleotide supplementation – often at 1g dosage – and the novel GLP-1 receptor agonist Retatrutide (or its related Tirzepatide). Specialists are observing potential